Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytokinetics

38.00
+0.19000.50%
Post-market: 39.191.19+3.13%18:37 EDT
Volume:1.19M
Turnover:45.93M
Market Cap:4.50B
PE:-7.22
High:39.73
Open:38.60
Low:37.90
Close:37.81
Loading ...

Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo

GlobeNewswire
·
17 Mar

Promising Progress and Positive Outlook for Cytokinetics’ Aficamten in oHCM Treatment

TIPRANKS
·
10 Mar

Cytokinetics regulatory update ‘incrementally positive,’ says Morgan Stanley

TIPRANKS
·
10 Mar

RBC Capital stays bullish on Cytokinetics on lack of AdCom in aficamten view

TIPRANKS
·
10 Mar

BRIEF-Cytokinetics maintains expectation For Differentiated Label & Risk Mitigation Profile for Aficamten if approved By FDA

Reuters
·
10 Mar

Cytokinetics: Maintain Expectation for Differentiated Label & Risk Mitigation Profile for Aficamten, IF Approved by FDA

THOMSON REUTERS
·
10 Mar

Cytokinetics assumed with an Overweight at Morgan Stanley

TIPRANKS
·
07 Mar

Cytokinetics (CYTK) Receives a New Rating from Morgan Stanley

TIPRANKS
·
07 Mar

Analysts Have Conflicting Sentiments on These Healthcare Companies: AnaptysBio (ANAB), Cytokinetics (CYTK) and uniQure (QURE)

TIPRANKS
·
06 Mar

B.Riley Financial Reaffirms Their Buy Rating on Cytokinetics (CYTK)

TIPRANKS
·
05 Mar

Revenue Downgrade: Here's What Analysts Forecast For Cytokinetics, Incorporated (NASDAQ:CYTK)

Simply Wall St.
·
05 Mar

Analysts Have Conflicting Sentiments on These Healthcare Companies: Owens & Minor (OMI), Acadia Healthcare (ACHC) and Cytokinetics (CYTK)

TIPRANKS
·
05 Mar

Cytokinetics to Participate in March Investor Conferences

GlobeNewswire
·
04 Mar

Cytokinetics Positioned for Growth with Aficamten’s Imminent Launch and Strong Financials

TIPRANKS
·
03 Mar

Cytokinetics (CYTK) Gets a Buy from Truist Financial

TIPRANKS
·
03 Mar

Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK), Warby Parker (WRBY) and 89bio (ETNB)

TIPRANKS
·
03 Mar

Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), DENTSPLY SIRONA (XRAY) and Cytokinetics (CYTK)

TIPRANKS
·
03 Mar

Cytokinetics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
01 Mar

Cytokinetics’ Earnings Call: Progress Amid Challenges

TIPRANKS
·
01 Mar

Cytokinetics Q4 Loss Wider Than Expected, Aficamten in Focus

Zacks
·
01 Mar